ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AGE AgeX Therapeutics Inc

0.3325
-0.0076 (-2.23%)
Dec 08 2023 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
AgeX Therapeutics Inc AGE AMEX Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0076 -2.23% 0.3325 19:44:19
Open Price Low Price High Price Close Price Prev Close
0.345 0.333 0.357 0.334 0.3401
more quote information »

Recent News

Date Time Source Heading
12/08/202316:05EDGAR2Form 8-K - Current report
12/01/202316:05EDGAR2Form 8-K - Current report
11/17/202316:05EDGAR2Form 8-K - Current report
11/16/202316:01EDGAR2Form SC 13D/A - General statement of acquisition of..
11/15/202309:38EDGAR2Form DEF 14A - Other definitive proxy statements
11/14/202316:25EDGAR2Form 8-K - Current report
11/14/202316:05BWAgeX Therapeutics Reports Third Quarter 2023 Financial..
11/07/202316:06EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
11/07/202316:05EDGAR2Form DEF 14A - Other definitive proxy statements
11/06/202316:05EDGAR2Form 8-K - Current report
11/01/202316:28EDGAR2Form SC 13D/A - General statement of acquisition of..
10/06/202316:05EDGAR2Form 8-K - Current report
9/22/202316:05EDGAR2Form PRE 14A - Other preliminary proxy statements
9/15/202316:05EDGAR2Form 8-K - Current report
9/08/202316:05EDGAR2Form 8-K - Current report
8/30/202316:05EDGAR2Form 425 - Prospectuses and communications, business..
8/30/202307:20EDGAR2Form 8-K - Current report
8/30/202307:00BWSerina Therapeutics and AgeX Therapeutics Enter into Merger..
8/25/202316:05EDGAR2Form 8-K - Current report
8/24/202316:48EDGAR2Form SC 13D/A - General statement of acquisition of..
8/21/202316:40EDGAR2Form 3 - Initial statement of beneficial ownership of..
8/14/202316:25EDGAR2Form 8-K - Current report
8/14/202316:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/14/202316:05BWAgeX Therapeutics Reports Second Quarter 2023 Financial..
8/04/202316:05EDGAR2Form 8-K - Current report
7/24/202318:28BWAgeX Therapeutics Closes $36,000,000 Debt Exchange for..
7/21/202317:32BWAgeX Therapeutics Announces $36,000,000 Debt Exchange for..
7/21/202317:29EDGAR2Form 8-K - Current report
7/07/202316:05EDGAR2Form 8-K - Current report
5/23/202316:05BWAgeX Therapeutics Announces Appeal of NYSE American..
5/12/202316:05BWAgeX Therapeutics Reports First Quarter 2023 Financial..
4/26/202316:05BWAgeX Therapeutics Receives Stock Exchange Deficiency Letter
3/31/202316:05BWAgeX Therapeutics Reports Fourth Quarter and Annual 2022..

Your Recent History

Delayed Upgrade Clock